• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

Establishment of new treatment with Menkes disease by disulriram

Research Project

  • PDF
Project/Area Number 21791011
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Pediatrics
Research InstitutionTeikyo University

Principal Investigator

FUJISAWA Chie  Teikyo University, 医学部, リサーチフェロー (10393000)

Co-Investigator(Renkei-kenkyūsha) WATTANAPPORN Bhadhaprasit  帝京大学, 医学部, リサーチフェロー (90583253)
Project Period (FY) 2009 – 2010
KeywordsMenkes病 / disulfiram / 銅代謝 / macularマウス / 治療 / 銅酵素活性
Research Abstract

Menkes disease (MD) is an X-linked recessive copper deficiency disorder with progressive neurological degeneration of copper metabolism caused by mutations in the ATP7A gene. It is not useful treatment for connective tissue and neurological degeneration. In this study, examined the effect of administration of combination with disulfiram and copper for macular mouse is a model for Menkes disease. It is suggested that combination with copper and disulfiram was useful methods for Menkes disease.

  • Research Products

    (3 results)

All 2010 Other

All Presentation (2 results) Remarks (1 results)

  • [Presentation] Effect of copper and Disulfiram combination therapy on the macular mouse, an animal model of Menkes disease.2010

    • Author(s)
      ワッタナポンペットパラシット、吉野美香、藤澤千恵、小川英伸、児玉浩子
    • Organizer
      第2回メタロミクス研究フォーラム
    • Place of Presentation
      京都薬科大学
    • Year and Date
      20101102-20101103
  • [Presentation] Effect of copper and Disulfiram combination therapy on the macular mouse, an animal model of Menkes disease.2010

    • Author(s)
      ワッタナポンペットパラシット、吉野美香、藤澤千恵、小川英伸、児玉浩子
    • Organizer
      第52回日本先天代謝異常学会総会・第9回アジア先天代謝異常症シンポジウム
    • Place of Presentation
      大阪国際会議場
    • Year and Date
      20101021-20101023
  • [Remarks] ホームページ等

URL: 

Published: 2012-02-13   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi